Papayannopoulou T, Nakamoto B, Yokochi T, Chait A, Kannagi R
Blood. 1983 Oct;62(4):832-45.
We investigated the effect of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) on the human erythroleukemia cell line, HEL, and found that TPA addition (10(-6)-10(-8) M) to HEL cell cultures induces morphological, functional, and biochemical changes in HEL cells that are characteristic for macrophage-like cells. Apart from the drastic changes in morphology, the cells greatly enhance their phagocytic ability and acquire receptors for binding and degradation of chemically modified lipoproteins. At the biochemical level, a newly synthesized 85K glycoprotein is observed, and the cells are unresponsive to inducers of globin synthesis. Comparative observations with K562 cells indicate that TPA inhibits, as in HEL cells, spontaneous and induced globin synthesis, but induces minimal macrophage-like properties in these cells. The results with HEL cells are interpreted to indicate that TPA uncovers a latent monocyte-like phenotype in these cells.
我们研究了12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)对人红白血病细胞系HEL的影响,发现向HEL细胞培养物中添加TPA(10⁻⁶ - 10⁻⁸ M)会诱导HEL细胞发生形态、功能和生化变化,这些变化是巨噬细胞样细胞的特征。除了形态上的剧烈变化外,细胞的吞噬能力大大增强,并获得了用于结合和降解化学修饰脂蛋白的受体。在生化水平上,观察到一种新合成的85K糖蛋白,并且细胞对珠蛋白合成诱导剂无反应。与K562细胞的对比观察表明,TPA与在HEL细胞中一样,抑制自发和诱导的珠蛋白合成,但在这些细胞中诱导出的巨噬细胞样特性极少。对HEL细胞的研究结果表明,TPA揭示了这些细胞中潜在的单核细胞样表型。